In this study, we confirmed the aberrant methylation of CDKN2A and MGMT promoter regions in LC (73% and 65%, respectively) and COPD (70% and 65%, respectively) compared with CTR (9% and 6%, respectively). This evidence concerns the gene CDKN2A and chronic obstructive pulmonary disease.